Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,308
Closed -$201K 1704
2025
Q4
$201K Sell
2,308
-2,788
-55% -$224K ﹤0.01% 1433
2025
Q3
$349K Buy
+5,096
New +$343K ﹤0.01% 1322
2025
Q2
Sell
-5,043
Closed -$298K 1613
2025
Q1
$298K Buy
5,043
+547
+12% +$34.4K ﹤0.01% 1279
2024
Q4
$278K Sell
4,496
-15,828
-78% -$1.03M ﹤0.01% 1305
2024
Q3
$1.22M Buy
20,324
+12,454
+158% +$687K 0.02% 725
2024
Q2
$402K Sell
7,870
-2,452
-24% -$125K 0.01% 1079
2024
Q1
$568K Sell
10,322
-2,337
-18% -$122K 0.01% 947
2023
Q4
$706K Sell
12,659
-2,846
-18% -$129K 0.01% 849
2023
Q3
$644K Buy
15,505
+1,786
+13% +$84.7K 0.01% 840
2023
Q2
$581K Buy
13,719
+6,030
+78% +$244K 0.01% 918
2023
Q1
$334K Buy
+7,689
New +$493K 0.01% 1103
2018
Q2
Sell
-8,593
Closed -$824K 1335
2018
Q1
$824K Sell
8,593
-9
-0.1% -$858 0.02% 674
2017
Q4
$747K Buy
+8,602
New +$692K 0.02% 715

Other funds holding CMA

Oppenheimer & Co's CMA Position: Q1 2026 in Review

Oppenheimer & Co sold out of Comerica (CMA) in Q1 2026, closing a stake of 2,308 shares — an estimated $201K sold.

Oppenheimer & Co first reported a position in CMA in Q4 2017 and held it in 13 quarters. The position peaked at $1.22M in Q3 2024. 4 funds tracked by Wall St. Rank hold CMA as of Q1 2026.

  • Oppenheimer & Co reported no remaining Comerica position as of Q1 2026 after selling out during the quarter.
  • Oppenheimer & Co sold 2,308 Comerica shares in Q1 2026, an estimated $201K.
  • Oppenheimer & Co first reported a position in Comerica in Q4 2017 and held it in 13 quarters.
  • Oppenheimer & Co's Comerica position peaked at $1.22M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Comerica as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.